A Study to Evaluate Same Day Discharge Post-mastectomy with/without Alloplastic Breast Reconstruction


About this study

In the light of the pandemic, institutions have had to take greater precautions and instigate procedures to aim to improve safety and reduce risk for patients undergoing surgery. One intiative was designed to implement a same day discharge for patients undergoing mastectomy with or without alloplastic reconstruction. This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and compare satisfaction and outcomes (e.g complications) with patients pre-COVID 19. This is part of a quality improvement project. 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All women over 18 years of age.
  • Undergoing skin sparing and nipple-sparing mastectomy, unilateral and bilateral, with or without immediate reconstruction with a tissue expander or direct to implant.
  • Data will also be collected from a comparative pre-COVID19 control group of women who underwent the same procedures and were discharged on post-operative day 1 (previous practice) and review 30 day clinical outcomes and operative details.
  • Women at least 18 years old.
  • Willingess to sign a HIPPA authorization form.

Exclusion Criteria:

  • Patients undergoing oncoplastic breast surgery.
  • Autologous reconstruction.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Aparna Vijayasekaran, M.B.B.S.

Contact us for the latest status

Contact information:

Anita Mohan M.B.B.S., Ph.D.


More information


Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions